-
Je něco špatně v tomto záznamu ?
Curcumin protects the seminal vesicles from metronidazole‑induced reduction of secretion in mice
Ali Noorafshan, Saied Karbalay‑Doust
Jazyk angličtina Země Česko Médium elektronický zdroj
Typ dokumentu práce podpořená grantem
Digitální knihovna NLK
Plný text - Článek
Číslo
Ročník
Zdroj
Zdroj
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2012-06-01
ROAD: Directory of Open Access Scholarly Resources
od 1997
- MeSH
- antiinfekční látky farmakologie MeSH
- kurkumin farmakologie MeSH
- metronidazol farmakologie MeSH
- myši inbrední BALB C MeSH
- myši MeSH
- semenné váčky sekrece účinky léků MeSH
- velikost orgánu účinky léků MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- práce podpořená grantem MeSH
Seminal vesicle secretion is important for increasing the stability of sperm chromatin, inhibition of the immune activity in the female reproductive tract and so on. Metronidazole (MTZ), a drug used for treatment of infections caused by anaerobic bacteria and protozoa, may have negative effects on the genital gland including the seminal vesicles. Curcumin exhibits antioxidant as well as anti-inflammatory properties. The present study aims to evaluate the negative effects of MTZ on the seminal vesicle structure and ameliorative effects of curcumin using stereological methods. Thirty balb/c mice were divided into six groups. The control group was received distilled water. The second and the third received higher doses of MTZ (500 mg/kg body weight/day) and MTZ (500 mg/kg/day) + 100 mg/kg/day curcumin, respectively. The fourth and the fifth were treated with lower doses of MTZ (165 mg/kg body weight/day) and MTZ (165 mg/kg body weight/day) + curcumin (100 mg/kg body weight/day), respectively. The sixth group received 100 mg/kg body weight/day curcumin. All the administrations were done by oral gavages for 14 days. After 30 days, seminal vesicles were removed. Stereological study of the seminal vesicle structure revealed a significant reduction in gland and vesicular fluid volume in MTZ-treated (higher or lower doses) animals. Curcumin protected the reduction of both parameters in therapeutic-dose treated animals. Metronidazole treatment does not induce structural changes in the seminal gland; however, it can have a significant impact on its secretion ability. Importantly, these deteriorations might be preventable by curcumin co-treatment.
Histomorphometry and Stereology Research Centre of Shiraz University of Medical Sciences Shiraz Iran
Curcumin protects the seminal vesicles from metronidazole‑induced reduction of secretion in mice [elektronický zdroj] /
Citace poskytuje Crossref.org
Obsahuje 1 tabulku
Bibliografie atd.Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12017015
- 003
- CZ-PrNML
- 005
- 20120719133018.0
- 007
- cr|cn|
- 008
- 120531s2012 xr f fs 000 0eng||
- 009
- eAR
- 024 7_
- $a 10.14712/18059694.2015.72 $2 doi
- 035 __
- $a (PubMed)22696933
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Noorafshan, Ali $u Histomorphometry & Stereology Research Centre of Shiraz University of Medical Sciences, Shiraz, Iran
- 245 10
- $a Curcumin protects the seminal vesicles from metronidazole‑induced reduction of secretion in mice $h [elektronický zdroj] / $c Ali Noorafshan, Saied Karbalay‑Doust
- 500 __
- $a Obsahuje 1 tabulku
- 504 __
- $a Literatura $b 30
- 520 3_
- $a Seminal vesicle secretion is important for increasing the stability of sperm chromatin, inhibition of the immune activity in the female reproductive tract and so on. Metronidazole (MTZ), a drug used for treatment of infections caused by anaerobic bacteria and protozoa, may have negative effects on the genital gland including the seminal vesicles. Curcumin exhibits antioxidant as well as anti-inflammatory properties. The present study aims to evaluate the negative effects of MTZ on the seminal vesicle structure and ameliorative effects of curcumin using stereological methods. Thirty balb/c mice were divided into six groups. The control group was received distilled water. The second and the third received higher doses of MTZ (500 mg/kg body weight/day) and MTZ (500 mg/kg/day) + 100 mg/kg/day curcumin, respectively. The fourth and the fifth were treated with lower doses of MTZ (165 mg/kg body weight/day) and MTZ (165 mg/kg body weight/day) + curcumin (100 mg/kg body weight/day), respectively. The sixth group received 100 mg/kg body weight/day curcumin. All the administrations were done by oral gavages for 14 days. After 30 days, seminal vesicles were removed. Stereological study of the seminal vesicle structure revealed a significant reduction in gland and vesicular fluid volume in MTZ-treated (higher or lower doses) animals. Curcumin protected the reduction of both parameters in therapeutic-dose treated animals. Metronidazole treatment does not induce structural changes in the seminal gland; however, it can have a significant impact on its secretion ability. Importantly, these deteriorations might be preventable by curcumin co-treatment.
- 650 02
- $a zvířata $7 D000818
- 650 02
- $a antiinfekční látky $x farmakologie $7 D000890
- 650 02
- $a kurkumin $x farmakologie $7 D003474
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a metronidazol $x farmakologie $7 D008795
- 650 02
- $a myši $7 D051379
- 650 02
- $a myši inbrední BALB C $7 D008807
- 650 02
- $a velikost orgánu $x účinky léků $7 D009929
- 650 02
- $a semenné váčky $x sekrece $x účinky léků $7 D012669
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Karbalay Doust, Saied
- 773 0_
- $t Acta medica (Hradec Králové) $x 1211-4286 $g Roč. 55, č. 1 (2012), s. 32–36 $w MED00010947
- 856 41
- $u https://actamedica.lfhk.cuni.cz/media/pdf/am_2012055010032.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 3077 $c 1072 $y 2
- 990 __
- $a 20120531144731 $b ABA008
- 991 __
- $a 20120719132931 $b ABA008
- 999 __
- $a ok $b bmc $g 910882 $s 774176
- BAS __
- $a 3 $a 4
- BMC __
- $a 2012 $b 55 $c 1 $d 32–36 $i 1211-4286 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
- LZP __
- $a 2012-10/mkme